Skip to main content
logo
Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.320
-0.040 (-1.69%)
Sep 9, 2026, 10:21 AM EDT - Market open

Lipocine Revenue

Lipocine had revenue of $190.10K in the quarter ending June 30, 2026, a decrease of -69.48%. This brings the company's revenue in the last twelve months to $1.57M, down -62.70% year-over-year. In the year 2025, Lipocine had annual revenue of $1.98M, down -82.35%.

Revenue (ttm)
$1.57M
Revenue Growth
-62.70%
P/S Ratio
12.40
Revenue / Employee
$112,104
Employees
14
Market Cap
19.13M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.98M-9.22M-82.35%
Dec 31, 202411.20M8.13M264.67%
Dec 31, 20233.07M2.57M514.16%
Dec 31, 2022500.00K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019164.99K-263.04K-61.45%
Dec 31, 2018428.03K--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 20127.71M--
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Cerenome4.20M
Dyadic International3.80M
Marker Therapeutics3.55M
Cyclerion Therapeutics1.90M
Neuphoria Therapeutics-13.27K
Revenue Rankings

LPCN News

More News